ELVN · Enliven Therapeutics, Inc. · Documents
$41.52
-0.41 (-0.98%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$3.04B
Shares
73.27M
Volume · Oct 23
2.3M
Avg daily vol (3M)
1.27M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| DEFA14A | — | 2021-05-18 | — | |
| DEF 14A | — | 2021-05-18 | 2021-06-29 | |
| 10-Q | — | 2021-05-11 | 2021-03-31 | |
| 8-K | — | 2021-05-11 | — | |
| 8-K | — | 2021-04-01 | — | |
| S-3 | — | 2021-04-01 | — | |
| 8-K | — | 2021-03-05 | — | |
| 10-K | — | 2021-03-05 | 2020-12-31 | |
| 10-Q | — | 2020-11-05 | 2020-09-30 | |
| 8-K | — | 2020-11-05 | — | |
| 10-Q | — | 2020-08-14 | 2020-06-30 | |
| 8-K | — | 2020-08-14 | — | |
| 10-Q | — | 2020-05-07 | 2020-03-31 | |
| 8-K | — | 2020-05-07 | — | |
| 8-K | — | 2020-04-23 | 2020-04-22 | |
| 8-K | — | 2020-03-16 | — | |
| S-1/A | — | 2020-03-10 | — | |
| S-1/A | — | 2020-03-03 | — | |
| S-1 | — | 2020-02-14 | — |
Showing 101–119 of 119 filings
Key facts
CIK
1672619
CUSIP
29337E102
13F (30d)
14 filings
14 filers
Visit website
Investor relations